• U.S. Treasury Chief Bessent claims China is now serious about curbing fentanyl flows amid escalating trade tensions.
  • The statement follows recent U.S. tariff hikes and accusations against Chinese officials for failing to stem precursor chemical shipments.
  • China had previously banned fentanyl variants in 2019, but U.S. officials say enforcement remains inconsistent.

Escalating Tensions Over Fentanyl

U.S. Treasury Chief Bessent asserted in a recent Fox Business interview that China has shifted its stance on fentanyl, signaling a newfound seriousness about halting the flow of the deadly opioid into the United States. The remarks come as trade relations between the two nations grow increasingly strained, with the Trump administration imposing additional tariffs earlier this year—partially justified by what it calls a "national emergency" tied to fentanyl trafficking.

Bessent warned that China would be the "loser" in any trade war, a pointed remark that underscores the broader economic and geopolitical friction surrounding the issue. His comments align with recent U.S. actions, including a February 2025 executive order imposing a 10% tariff on Chinese imports, citing the need to combat drug trafficking and money laundering by transnational criminal organizations.

Enforcement and Denials

China has long denied being the primary source of U.S.-bound fentanyl, despite DEA data showing that seizures of banned analogs dropped when China imposed restrictions. In 2019, Beijing expanded its ban to cover all fentanyl-related substances, but U.S. officials argue enforcement has been inconsistent. A recent white paper released by China’s State Council Information Office, titled "Controlling Fentanyl-Related Substances – China's Contribution," suggests renewed efforts—though specifics on enforcement remain unclear.

Meanwhile, the U.S. continues to escalate economic pressure, with the USTR finalizing new port service fees on Chinese-linked vessels in April 2025. While unrelated to fentanyl, the move signals Washington’s willingness to leverage trade policy in broader disputes.

What Comes Next?

If China follows through on Bessent’s claims, it could mark a turning point in bilateral cooperation on narcotics enforcement. However, skepticism remains high among U.S. officials, who have accused Chinese entities of facilitating precursor chemical shipments to cartels. Without verifiable crackdowns, the issue is likely to remain a flashpoint in ongoing trade negotiations.